|
|
|
|
| LEADER |
03023nam a22003495i 4500 |
| 001 |
000291089 |
| 005 |
20210603091115.0 |
| 007 |
cr nn 008mamaa |
| 008 |
150130s2014 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781493912896
|
| 024 |
7 |
|
|a 10.1007/978-1-4939-1289-6
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Topical Drug Bioavailability, Bioequivalence, and Penetration /
|c edited by Vinod P. Shah, Howard I. Maibach, John Jenner.
|
| 250 |
|
|
|a 2nd ed. 2014.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2014.
|
| 300 |
|
|
|a XIII, 402 p. 64 illus., 16 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a 1 Percutaneous Absorption -- 2 Animal Models for Percutaneous Absorption -- 3 Mitigating Dermal Exposure to Agrochemicals -- 4 Importance of In Vitro Drug Release -- 5 Diffusion Cell Design -- 6 In Vitro Product Quality Tests and Product Performance Tests for Topical and Transdermal Drug Products -- 7 Safety and efficacy testing of topical products; Practical considerations -- 8 Challenges in Evaluating Bioequivalence of Topical Dermatological Drug Products -- 9 Methods for the Assessment of Bioequivalence of Topical Dosage Forms: Correlations, Optimization Strategies and Innovative Approaches -- 10 Application of Microdialysis in Assessing Cutaneous Bioavailability -- 11 Follicular Drug Penetration -- 12 Development of Pilosebaceous Unit-Targeted Drug Products -- 13 Deep Percutaneous Penetration into Muscles and Joints: Update -- 14 Efficacy & Toxicity of Microneedle based devices -- 15 Mathematical Models for Topical and Transdermal Drug Products -- 16 Transdermal Patches: An Industrial Perspective on the Relevance of in vitro Skin Permeation Studies and Approaches on Design of Manufacturing Processes -- 17 Transdermal Drug Delivery Systems. Regulatory Considerations: NDA and ANDA Requirements -- 18 Transdermal Estradiol and Testosterone Transfer in Man: Existence, Models, and Strategies for Prevention -- 19 Effects of occlusion on dermal drug delivery: implications for bioequivalence measurement -- 20 Challenges with Clinical Endpoints – Bioequivalence -- 21 Clinical Considerations of Bioequivalence For Topical Dermatologic Drugs -- 22 OECD Test Guideline 428 – A method for in vitro percutaneous absorption measurement? -- 23 Bioequivalence, Quality, and Novel Assessment Technologies for Topical Products: Current Challenges and Future Prospects.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Animal physiology.
|
| 650 |
|
0 |
|a Biophysics.
|
| 650 |
|
0 |
|a Biological physics.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Animal Physiology.
|
| 650 |
2 |
4 |
|a Biological and Medical Physics, Biophysics.
|
| 700 |
1 |
|
|a Shah, Vinod P.
|e editor.
|
| 700 |
1 |
|
|a Maibach, Howard I.
|e editor.
|
| 700 |
1 |
|
|a Jenner, John.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|